The Univeristy of Melbourne The Royal Melbourne Hopspital

A joint venture between The University of Melbourne and The Royal Melbourne Hospital

Meet our graduate researchers

When considering a PhD, choosing the right place to study is a major factor.

The Doherty Institute is home to graduate researchers from all over the world with different backgrounds, interests and motivations. We asked our current graduate researchers to tell us about their research, explain why they chose to study at the Doherty Institute and also provide some advice to prospective PhD applicants.

Dr Alex Stewart

Alex commenced a PhD with the McCarthy Group in 2022.

Research title: The role of cytochrome polymorphisms in primaquine metabolism and effects on its activity in radical cure of Plasmodium vivax infection.

▷ Hear from Alex

Daniel Rawlinson

Daniel commenced a PhD with the Coin Group in 2021.

Research title: The Applications and Limitations of CITE-seq for Immune Cell Profiling.

▷ Hear from Daniel

Elise Mitri

Elise commenced a PhD with the Trubiano Group in 2023.

Research title: Multi-disciplinary Health Services Approaches to Low-risk Penicillin Allergy Delabelling

▷ Hear from Elise

Magnus Jespersen

Magnus commenced a PhD with the Davies Group in 2019.

Research title: Characterising the molecular drivers of group A Streptococcal evolution

▷ Hear from Magnus

Dr Michael Moso

Dr Michael Moso commenced a PhD with the Lewin Group in 2023.

Research title: Nanoparticle and gene therapy approaches to HIV cure.

▷ Hear from Michael

Navneet Kaur

Navneet commenced a PhD with the McDevitt Group in 2020.

Research title: Structural and Functional Characterisation of the WalK histidine kinase from Staphylococcus aureus.

▷ Hear from Navneet

Dr Neta Petersiel

Neta commenced a PhD with the Tong Group in 2022.

Research title: Are MRSA β-lactam susceptibility phenotypes and genotypes associated with treatment response and clinical outcomes in MRSA bloodstream infections?  

▷ Hear from Neta

Dr Ouli Xie

Dr Ouli Xie commenced a PhD with the Tong and Davies Group in 2022.

Research title: Evolution of streptococcal pathovars. 

▷ Hear from Oulie

Dr Rendi Moke

Rendi commenced a PhD with the Coin Group in 2023.

Research title: Prospective study of treatment outcomes on the shorter treatment regimen among drug resistant tuberculosis with various mutations.

▷ Hear from Rendi

Dr Stephen Muhi

Stephen commenced a PhD with the Stinear Group in 2021.

Research title: Novel strategies to diagnose and control emerging infectious diseases.

▷ Hear from Stephen

Current research projects available